AKT1 and breast carcinoma: Our group previously developed Ehop-016, a small molecule inhibitor of Rac with an IC50 of 1 μM in metastatic breast cancer cells (Dharmawardhanane et al. 2013; Castillo-Pichardo et al. 2014; Montalvo-Ortiz et al. 2012).